CRNX · Crinetics Pharmaceuticals, Inc.
$83.90
+0.03 (+0.04%)
At close · Jul 21
Market Cap
$8.85B
Shares
105.44M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-07-10 | 2026-07-06 | |
| 8-K | 2026-07-06 | — | |
| 8-K | 2026-06-22 | 2026-06-18 | |
| 8-K | 2026-05-07 | — | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| DEF 14A | 2026-04-29 | 2026-06-18 | |
| 8-K | 2026-04-10 | — | |
| 8-K | 2026-03-23 | 2026-03-17 | |
| 8-K | 2026-03-03 | 2026-02-27 | |
| 8-K | 2026-02-26 | — | |
| 10-K | 2026-02-26 | 2025-12-31 | |
| 8-K | 2026-01-26 | 2026-01-20 | |
| 8-K | 2026-01-13 | — | |
| 8-K | 2026-01-07 | 2026-01-05 | |
| 8-K | 2026-01-05 | — | |
| 8-K | 2025-12-17 | 2025-12-16 | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-11-06 | — | |
| 8-K | 2025-09-26 | 2025-09-25 | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-08-07 | — | |
| 8-K | 2025-06-30 | — | |
| 8-K | 2025-06-26 | — | |
| 8-K | 2025-06-12 | 2025-06-11 | |
| 10-Q | 2025-05-08 | 2025-03-31 | |
| 8-K | 2025-05-08 | — | |
| DEF 14A | 2025-04-23 | 2025-06-11 | |
| 8-K | 2025-04-04 | 2025-04-01 | |
| 8-K | 2025-02-27 | — | |
| 10-K | 2025-02-27 | 2024-12-31 | |
| 8-K | 2025-02-24 | 2025-02-21 | |
| 8-K | 2025-01-14 | — | |
| 8-K | 2025-01-10 | — | |
| 8-K | 2024-12-16 | — | |
| 8-K | 2024-12-09 | — | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| 8-K | 2024-11-12 | — | |
| 8-K | 2024-10-16 | 2024-10-10 | |
| 8-K | 2024-10-09 | 2024-10-08 | |
| 8-K | 2024-09-26 | — | |
| 8-K | 2024-09-17 | 2024-09-13 | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-08-08 | 2024-08-05 | |
| 8-K | 2024-06-21 | — | |
| 8-K | 2024-06-10 | 2024-06-07 | |
| 8-K | 2024-06-03 | — | |
| 8-K | 2024-05-22 | — | |
| 8-K | 2024-05-09 | — | |
| 10-Q | 2024-05-09 | 2024-03-31 | |
| 8-K | 2024-05-08 | — |
Showing 1–50 of 137 filings
Key facts
CIK
1658247
CUSIP
22663K107
13F (30d)
24 filings
23 filers
Visit website
Investor relations